Ravgen continues its legal revenge saga with a $57M verdict over Natera

Ravgen, a company that was a blip in prenatal screening not long ago, has continued its streak of legal victories against much larger companies thanks to another multimillion-dollar verdict.

Natera must pay Ravgen $57 million for infringing on a Ravgen patent, a jury in the US District Court for the…
Click here to view original post